arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

Teladoc Health, Inc.

TDOC
$9.42 ▼ -0.27 (-2.79%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
53 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

Teladoc Health, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B
Dividend Yield —
Revenue Growth -3.4% ↗
Op. Margin -4.6% ↗
ROIC -2.2% ↗
FCF / Share $0.58 ↗
Trailing P/E —
Price / Book 1.3x
FCF Yield 6.1%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

53-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$605.10M
↓ -3.4% —
Net Income Profit after all expenses
$-26.93M
↑ +45.6% —
Operating Margin Operating profit as % of sales
-4.6%
↑ +24.0% 15th
FCF / Share Free cash flow per share
$0.58
↑ +64.4% —
Long-Term Debt Long-term obligations
$42.43M
— -0.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
33
Returns ↓
31
Cash Quality ↓
8

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 53 quarters